Clinical Research Advantage, Inc. Acquires Late Phase Division of Comprehensive Clinical Development

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TEMPE, Ariz.--(BUSINESS WIRE)--Clinical Research Advantage (CRA), the country’s largest wholly owned network of clinical trial sites, has further expanded its geographic and therapeutic reach by acquiring the late phase division of Comprehensive Clinical Development (CCD). This transaction will allow CRA to offer pharmaceutical sponsors and contract research organizations an across-the-board solution for their diverse clinical research needs.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC